Five-Year Results With Patisiran for hATTR-PN
This open-label extension of a randomized clinical trial evaluates 5-year safety and efficacy of patisiran for the treatment of hereditary transthyretin amyloidosis with polyneuropathy.
Related Articles
Cerebral Embolic Protection by Geographic Region
This randomized clinical trial evaluates regional differences in the association between stroke outcomes and cerebral embolic protection.
Doxycycline Postexposure Prophylaxis and Sexually Transmitted Infection Trends
This study assesses the association of citywide doxycycline postexposure prophylaxis guideline release with reported chlamydia, gonorrhea, and early syphilis cases in men who have sex…
Diet Quality, Dietary Inflammatory Potential, and Risk of Prostate Cancer Grade Reclassification
This cohort study examines whether there is an association of diet quality and dietary inflammatory potential with prostate cancer grade reclassification in men with grade…
Tralokinumab and Acitretin in Lamellar Ichthyosis
This case report describes a man in his 30s who presented with severe and generalized congenital ichthyosis and was treated with a combination of tralokinumab…
Antipsychotic Drugs and Cognitive Function
This systematic review and network meta-analysis evaluates associations between antipsychotic drugs and cognitive function, quality of life, and social functioning.
Cotton Swab Couching of Dislocated Crystalline Lens in Marfan Syndrome
This case report discusses use of bedside manual repositioning of an anteriorly dislocated crystalline lens in a patient with Marfan syndrome.
The European Journal of Neurology: 2025 and Beyond – eanpages
The EAN is pleased to announce that Prof. Claudia Sommer will be the next Editor-in-Chief of the European Journal of Neurology.
Frontiers | Domain adaptation spatial feature perception neural network for cross-subject EEG emotion recognition
Wei Lu 1,2 Xiaobo Zhang 2,3 Lingnan Xia 1 Hua Ma 1 * Tien-Ping Tan 2 * 1 Henan High-speed Railway Operation and Maintenance Engineering…
Podcasts
Leaders from across the neurocritical care space find their voice on the Neurocritical Care Society’s podcast. Tune in from your favorite podcast listening platform.
Androgen Receptor Pathway Inhibitor Therapy for Advanced Prostate Cancer
This prespecified secondary analysis of a randomized clinical trial investigates the association of apalutamide alone or apalutamide plus abiraterone acetate and prednisone with health-related quality…
